A clinical-trial provider sued psychedelic therapy developer Definium Therapeutics on Monday in Delaware federal court, ...

Sparrow Pharmaceuticals, a targeted cardiometabolic therapeutics company, today announced the appointment of Carlo Incerti, M.D., to its Board of Directors, effective January 1, 2026. Dr. Incerti is a ...

Researchers assess the adequacy of tissue ablation by a cooled laser therapy in patients with localized prostate cancer.

MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCMSOUTH SAN FRANCISCO, Calif., ...

Dr. Taz Bhatia M.D., a nationally recognized integrative medicine physician, author, and founder of hol+, has partnered with nonprofit Countdown for a Cure (CFAC) to help advance awareness, education, ...

Researchers at the University of Colorado Anschutz Linda Crnic Institute for Down Syndrome (Crnic Institute) have uncovered ...

Researchers at the University of Colorado Anschutz Linda Crnic Institute for Down Syndrome (Crnic Institute) have uncovered ...

DENVER, CO / / January 20, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous ...

At Stanford, a treatment that aims magnetic pulses at the brain is showing results for people with treatment-resistant depression. It’s called SAINT, and here’s how it works.

The program’s executive-friendly approach allows guests to maintain professional responsibilities while in treatment. Electronic-friendly policies, private accommodations with en suite bathrooms, ...

Those who study the brain or treat patients (or both) talk a lot about executive functioning, often in the negative. We refer to “poor executive functioning,” “executive dysfunction,” “frontal lobe ...